Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres

Pharmaceutical Development and Technology

Volumn 12, Issue 1, 2007, Pages 79-88

  Vivek, K ^a   Reddy, L Harivardhan ^a   Murthy, R S R ^a,b  

^a Pharmacy Department   (India)

^b M S UNIVERSITY OF BARODA   (India)

Author keywords

Drug release; Etoposide; Microspheres; PLGA; Polycaprolactone

Indexed keywords

BUFFER; ETOPOSIDE; MICROSPHERE; PHOSPHATE; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; ANTINEOPLASTIC AGENT; ELECTROLYTE; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYVINYL ALCOHOL; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION; DISSOLUTION; DRUG FORMULATION; DRUG MIXTURE; EMULSION; EVAPORATION; PH; PRIORITY JOURNAL; BIODEGRADABLE IMPLANT; CHEMISTRY; COMPARATIVE STUDY; DRUG IMPLANT; KINETICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; SOLUBILITY;

ABSORBABLE IMPLANTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DRUG COMPOUNDING; DRUG IMPLANTS; ELECTROLYTES; ETOPOSIDE; KINETICS; LACTIC ACID; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; POLYVINYL ALCOHOL; SOLUBILITY;

EID: 34249662191     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450601168581     Document Type: Article

References (23)

1. Indu Bala; Sarita Hariharan; Ravi Kumar M.N.V. PLGA Nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carr. Syst. 2004, 21 (5), 387-422.
2. Beck, L.R.; Cowsar, D.R.; Lewis, D.H.; Cosgrove, R.J.; Riddle, C.T.; Lowry, S.L.; Epperly, T. A new long-acting injectable microcapsule system for the administration of progesterone. Fertil. Steril. 1979, 31 (5), 545-548.
3. Fu Y.J.; Mi F.L.; Wong T.B.; Shyu S.S. Characteristic and controlled release of anticancer drug loaded poly (D, L, lactide) microparticles prepared by spray drying technique. J. Microencapsul. 2001, 18 (6), 733-747.
4. Lewis, D. H. Controlled release of bioactive agents from lactide/glycolide polymers. In the Biodegradable Polymers as Drug Delivery Systems; Chasin N.; Langer, R., Eds.; Dekker: New York, 1990, 1-41.
5. Slevin M. The clinical pharmacology of etoposide. Cancer 1991, 67, 31-39.
6. Ashley D.; Meier L.; Kerby T.; Zlduondo F.; Friedman H.; Gajjar A.; Kun L., Duffner P.; Smith S.; Longee D. Response of recurrent medulloblastoma to low-dose oral etoposide. J. Clin. Oncol. 1996, 14 (6), 1922-1927.
7. Chamberlain, M. Recurrent brainstem gliomas treated with oral VP-16. J. Neuro-oncol. 1993, 15 (2), 133-139.
8. Subramanian N.; Murthy R.S.R. Use of electrolyte induced flocculation technique for an in vitro steric stability study of steric study of steric stabilized liposome formulations. Pharmazie 2003, 59, 74-76.
9. Henry R. Costantino; Laleh Firouzabadian; Ken Hogeland; Chichih Wu; Chris Beganski; Kai Greibenow; Stephen E. Zale; Mark A. Tracy. Protein spray - freeze drying. Effect of atomization conditions on particle size and stability. Pharm. Res. 2000, 17 (11), 1374-1383.
10. Matthew J. Schaefer; Jagdish Singh. Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres. AAPS Pharm. Sci. Tech. 2000, 1 (4) article 32.
11. Sanjeeb K. Sahoo; Jayanth Panyam; Swayam Prabha; Vinod Labhasetwar. Residual polyvinyl alcohol associated with poly (D, L-lactide-coglycolide) nanoparticles affects their physical properties and cellular uptake. J. Control. Release 2002, 82 (1), 105-114.
12. Boury F.; Ivanova T.; Panaiotov I. Dynamic properties of poly (D, L-lactide) and polyvinyl alcohol monolayers at the air/water and dichloromethane air/water interfaces. J. Colloid. Interf. Sci. 1995, 169, 380-392.
13. Mesens J.; Rickey M.E.; Atkins T.J. Microencapsulated 3-piperidinyl substituted 1, 2 benzisoxazoles and 1, 2 benzisothiazoles, US Patent no. 6,803,055. October 12, 2004.
14. Huang S.K.; Martin F.J.; Jay. G.; Vogel. J.; Papahajopoulos D.; Friend DS. Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing HIV Tat gene. Am. J. Pathol. 1993, 143 (1), 10-14.
15. Eliza R.E.; Kost J. Characterization of a polymeric PLGA injectable implant delivery system for the controlled release of proteins. J. Biomed. Mater. Res. 2002, 50, 388-396.
16. Li S.M.; Garreau H; Vert M. Structure-property relationship in the case of the degradation of massive aliphatic poly-(-hydroxy acids) in aqueous media. 1 Degradation of lactide-glycolide copolymers: PLA37.5GA25 and PLA75GA25. J. Mat. Sci. Mater. Med. 1990, 1, 131.
17. Lin S.Y.; Chen K.S.; Teng H.H.; Li M.J. In vitro degradation and dissolution behaviors of microspheres prepared by three low molecular weight polyesters. J. Microencapsul. 2000, 17 (5), 577-586.
18. Jain R.A.; Rhodes C.T.; Railkar A.M.; Malick A.W.; Shah N.H. Controlled delivery of drugs from a novel injectable in situ formed biodegradable PLGA microsphere system. J. Microencapsul. 2000, 17 (3), 343-362.
19. Shah, S.S.; Gha, Y.; Pitt, C.G. Poly (lactic acid-co-dl-lactic acid): diffusion or degradation controlled delivery? J. Control. Release 1992, 18, 261-270.
20. Jeyanthi, R.; Mehta R.C.; Thanoo B.C.; DeLuca, P.P.; Effect of manufacturing parameters on the properties of peptide-containing PLGA microspheres. J. Microencapsul. 1997, 14 (2), 163-174.
21. Siepmann J.; Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Deliv. Rev. 2001, 48 (2-3), 139-157.
22. Soo P.L. Incorporation and release of hydrophobic probes in biocompatible polycaprolactone-block-poly (ethylene oxide) micelles: implications for drug. Langmuir 2002, 18, 9996-10004.
23. Wagner, J. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J. Pharm. Sci. 1969, 58, 1253-1256.